Cystic Fibrosis Australia (CFA) is the national body for cystic fibrosis and works with State and Territory partners to achieve national priorities: including ensuring the availability and accessibility of new treatments, funding vital research, advocating for increased support and quality improvement programs for people with cystic fibrosis.
Who is Cystic Fibrosis Australia?
Cystic Fibrosis Australia (CFA) is the national body for cystic fibrosis and works with State and Territory partners to achieve national priorities: including ensuring the availability and accessibility of new treatments, funding vital research, advocating for increased support and quality improvement programs for people with cystic fibrosis.
How does Cystic Fibrosis Australia help the Australian community?
Cystic Fibrosis Australia has three strategic pillars:
Collaboration Funding Advocacy
CFA Collaborates with:
-
State and Territory cystic fibrosis organisations
-
The Australian Cystic Fibrosis Research Trust (ACFRT) and researchers across Australia
-
Other Not For Profit organisations in the chronic disease sector both here in Australia and Overseas
-
Pharmaceutical companies for knowledge sharing and to ensure that drugs are developed to combat cystic fibrosis
-
The Federal Government to ensure people with cystic fibrosis have access to the best treatments and medical care
-
Media to improve the profile of the disease and make sure information in the public domain is correct.
CFA sources funding through:
-
National fundraising campaigns and marketing initiatives
-
Corporate sponsorships
-
Pharmaceutical company partnerships
-
Social ventures and public appeals
-
Community fundraisers and donors
CFA advocacy program is designed to engage with:
-
A number of Federal Government departments, the Pharmaceutical Benefits Advisory Committee (PBAC), eHealth and the Therapeutic Goods Administration (TGA)
-
State and Territory cystic fibrosis organisations
-
Clinicians, researchers and health professionals across Australia